In recent years, much attention has been given to the subject of patient rights; be this in the form of patient-centricity efforts, which place the individual at the heart of research and t
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS